Blaubeuren, Germany

Stefan Laufer

USPTO Granted Patents = 21 


 

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 141(Granted Patents)


Location History:

  • Blaubeuren, DE (1999 - 2008)
  • Bleubeuren, DE (2009)
  • Tubingen, DE (2013 - 2014)
  • Tübingen, DE (2011 - 2024)

Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: **Stefan Laufer: Innovator in Liver Regeneration**

Introduction

Stefan Laufer, a distinguished inventor based in Blaubeuren, Germany, has made significant contributions to the field of biochemistry, particularly through his innovative work on protein kinase inhibitors. With a remarkable portfolio of 19 patents, Laufer's research aims to advance therapeutic options for liver injuries and associated diseases.

Latest Patents

Among his latest innovations are compounds that function as protein kinase inhibitors, specifically targeting MKK4 (mitogen-activated protein kinase kinase 4). These compounds have been designed to promote liver regeneration and prevent hepatocyte death, crucial findings for treating liver-related issues. The invention details compounds of a specific formula that selectively inhibit MKK4 over other protein kinases, providing a focused approach to therapy. Additionally, his research has developed pyrazolo-pyridine compounds that serve a similar function, suggesting potential applications in treating osteoarthritis, rheumatoid arthritis, and CNS-related diseases.

Career Highlights

Stefan Laufer has cultivated a successful career in pharmaceutical research, holding key positions in reputable companies such as Merckle GmbH and Heparegenix GmbH. His dedication to uncovering novel therapeutic pathways has positioned him as a prominent figure in his field, contributing valuable insights that have paved the way for new treatment modalities.

Collaborations

Throughout his career, Laufer has collaborated with notable professionals, including Wolfgang Albrecht and Hans-Guenter Striegel. These partnerships have enhanced his research endeavors, fostering a collaborative spirit that drives innovation and discovery in the biochemistry landscape.

Conclusion

Stefan Laufer stands out as a pivotal inventor with a focus on advancing liver health through targeted pharmacological strategies. His extensive patent portfolio reflects his commitment to research and development, promising significant contributions to medical science and patient care in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…